SEC Form 4 · accession 0001140361-15-035226
Asterias Biotherapeutics, Inc. · AST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katharine E. Spink
Officer — VP and Chief Operating Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 16, 2015 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001572552
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Sep 15, 2015 | S | 3,760 | $6.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 30, 2015.